Therapeutic potential of interleukin-27 against cancers in preclinical mouse models

Since we first reported the antitumor efficacy of IL-27 in 2004, accumulating evidence obtained by several groups using a variety of preclinical mouse models indicates that IL-27 possesses potent antitumor activity against various types of tumors through multiple mechanisms depending on the characte...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncoimmunology
Egile Nagusiak: Mizoguchi, Izuru, Chiba, Yukino, Furusawa, Jun-ichi, Xu, Mingli, Tsunoda, Ren, Higuchi, Kaname, Yoshimoto, Takayuki
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Taylor & Francis 2015
Gaiak:
Author's View
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4589049/
https://ncbi.nlm.nih.gov/pubmed/26451308
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1042200
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak